﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>IOM Topic: Substance Abuse and Mental Health</title><link>http://www.feedburner.com</link><description>Institute of Medicine RSS feed for the following topic: Substance Abuse and Mental Health</description><item><title>Sex Differences and Implications for Translational Neuroscience Research - Workshop Summary</title><description>Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.</description><link>http://www.iom.edu/Reports/2010/Sex-Differences-and-Implications-for-Translational-Neuroscience-Research.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Increasing Quality of Care - Workshop Summary</title><description>Millions of people in sub-Saharan Africa suffer from mental, neurological, and substance use (MNS) disorders, and most do not have the resources to obtain treatment. The Uganda National Academy of Sciences and the IOM hosted a workshop to discuss the state of care for MNS disorders in sub-Saharan Africa.</description><link>http://www.iom.edu/Reports/2010/Mental-Neurological-and-Substance-Use-Disorders-in-Sub-Saharan-Africa-Reducing-the-Treatment-Gap-Increasing-Quality-of-Care.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System – A Workshop</title><description>Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer’s, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The IOM’s Forum on Neuroscience and Nervous System Disorders held a workshop June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers.</description><link>http://www.iom.edu/Reports/2011/Glutamate-Related-Biomarkers-in-Drug-Development-for-Disorders-of-the-Nervous-System.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>CNS Clinical Trials: Suicidality and Data Collection - Workshop Summary</title><description>The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system—including psychiatric drugs—are assessed for whether that drug might cause suicidal ideation or behavior. The IOM’s Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA’s new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.</description><link>http://www.iom.edu/Reports/2010/CNS-Clinical-Trials-Suicidality-and-Data-Collection.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>Alzheimer’s Diagnostic Criteria Validation: Exploration of Next Steps</title><description>Presentation at the Alzheimer's Association International Conference on Alzheimer's Disease 2011 </description><link>http://www.iom.edu/Activities/Research/NeuroForum/2011-JUL-18.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>Workshop on Glutamate-related Biomarkers in Drug Development for Disorders of the Nervous System </title><description>The goal of the workshop was to present promising current and emerging technologies with potential as reliable glutamate biomarkers, and to outline strategies to accelerate development, validation, and implementation of these biomarkers as powerful tools to advance drug development for nervous system disorders associated with glutamatergic dysfunction.</description><link>http://www.iom.edu/Activities/Research/NeuroForum/2010-JUN-21.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>Workshop on Quality of Care Issues for Mental Health and Neurological Disorders in Sub-Saharan Africa</title><description>The workshop brought together key stakeholders to assess the current state of the quality of care for neurological, mental, and substance use disorders in sub-Saharan Africa.</description><link>http://www.iom.edu/Activities/Research/NeuroForum/2009-AUG-04.aspx</link><pubDate>6/24/2015</pubDate></item><item><title>From Molecules to Minds: Challenges for the 21st Century. Workshop Summary</title><description>On June 25, 2008, the IOM Forum on Neuroscience and Nervous System Disorders hosted more than 70 of the leading neuroscientists in the world, for a workshop titled From Molecules to Minds: Challenges for the 21st Century. The objective of the workshop was to explore a set of common goals or “Grand Challenges” posed by participants that could inspire and rally both the scientific community and the public to consider the possibilities for neuroscience in the 21st century.</description><link>http://www.iom.edu/Reports/2008/From-Molecules-to-Minds-Challenges-for-the-21st-Century.aspx</link><pubDate>6/23/2015</pubDate></item><item><title>Forum on Global Violence Prevention</title><description>Preventable violence is a major public health problem worldwide. The IOM's Forum on Global Violence Prevention works to reduce violence worldwide through the promotion of multidisciplinary research emphasizing the value of prevention.</description><link>http://www.iom.edu/Activities/Global/ViolenceForum.aspx</link><pubDate>6/22/2015</pubDate></item><item><title>Preventing Intimate Partner Violence in Uganda, Kenya, and Tanzania: Summary of a Joint Workshop by the Institute of Medicine, the National Research Council, and the Ugandan National Academy of Sciences</title><description>On August 11–12, 2014, the Institute of Medicine’s (IOM’s) Forum on Global Violence Prevention, in a collaborative partnership with the Uganda National Academy of Sciences (UNAS),  convened a workshop focused on informing and creating synergies within a diverse community of researchers, health workers, and decision makers committed to promoting IPV-prevention efforts that are innovative, evidence-based, and crosscutting. This collaborative workshop also fulfills the forum’s mandate, which in part requires it to engage in multisectoral, multidirectional dialogue that explores crosscutting approaches to violence prevention.</description><link>http://www.iom.edu/Reports/2015/Preventing-Intimate-Partner-Violence-Uganda-Kenya-Tanzania.aspx</link><pubDate>6/17/2015</pubDate></item><item><title>Third Meeting of the Committee to Evaluate the Social Security Administration's Capability Determination Process for Adult Beneficiaries</title><description>Third Meeting of the Committee to Evaluate the Social Security Administration's Capability Determination Process for Adult Beneficiaries</description><link>http://www.iom.edu/Activities/HealthServices/SSACapabilityDetermination/2015-JUN-24.aspx</link><pubDate>6/15/2015</pubDate></item><item><title> Second Meeting of the Committee to Evaluate the Social Security Administration's Capability Determination Process for Adult Beneficiaries will take place on April 21, 2015 in Washington DC.</title><description> Second Meeting of the Committee to Evaluate the Social Security Administration's Capability Determination Process for Adult Beneficiaries will take place on April 21, 2015 in Washington DC.</description><link>http://www.iom.edu/Activities/HealthServices/SSACapabilityDetermination/2015-APR-21.aspx</link><pubDate>6/11/2015</pubDate></item><item><title>Forum on Neuroscience and Nervous System Disorders</title><description>The IOM's Forum on Neuroscience and Nervous System Disorders focuses on building partnerships to further understand the brain and nervous system, disorders in their structure and function, as well as effective clinical prevention and treatment strategies.</description><link>http://www.iom.edu/Activities/Research/NeuroForum.aspx</link><pubDate>5/27/2015</pubDate></item><item><title>The Neuroscience of Gaming: Workshop in Brief</title><description>More than 1.2 billion people worldwide play video games (online, via console, mobile phone, and other wireless devices), and many may be unaware that programmers often incorporate neuroscience into game design. Given the high prevalence of gaming in today’s society, the Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders hosted the Social Issues Roundtable at the Society for Neuroscience annual meeting on November 16, 2014, in Washington, DC, to explore the neuroscience of video games, with emphasis on relevant scientific, ethical,and societal issues.</description><link>http://www.iom.edu/Reports/2015/Neuroscience-Gaming-WIB.aspx</link><pubDate>5/26/2015</pubDate></item><item><title>Psychological Testing, Including Validity Testing, for Social Security Administration Disability Determinations</title><description>The IOM will conduct a study to evaluate the value of psychological testing in the adjudication of disability claims submitted to the Social Security Administration (SSA) Disability Programs.</description><link>http://www.iom.edu/Activities/SelectPops/TestingSSADisability.aspx</link><pubDate>5/14/2015</pubDate></item><item><title>Forum on Promoting Children's Cognitive, Affective, and Behavioral Health</title><description>Cognitive, affective, and behavioral disorders incur high psychosocial and economic costs for the young people who experience them, for their families, and for the communities in which they live, study, and will work. The Forum on Promoting Children’s Cognitive, Affective, and Behavioral Health was established as an outgrowth of the 2009 Institute of Medicine-National Research Council report “Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities” which called on the nation to make the prevention of such disorders and the promotion of mental health of young people a high priority. </description><link>http://www.iom.edu/Activities/Children/ChildrensHealthForum.aspx</link><pubDate>5/14/2015</pubDate></item><item><title>New Workshop Summary: Developing a 21st Century Neuroscience Workforce</title><description>The Institute of Medicine Releases a new Workshop Summary: Developing a 21st Century Neuroscience Workforce: Workshop Summary</description><link>http://www.iom.edu/Activities/Research/NeuroForum/Training Report.aspx</link><pubDate>4/21/2015</pubDate></item><item><title>Improving Access to Essential Medicines for Mental, Neurological and Substance Use Disorders in Sub-Saharan Africa: A Workshop</title><description>An IOM committee will host a 2-day workshop in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to essential medicines for MNS disorders.</description><link>http://www.iom.edu/Activities/Research/NeuroForum/2014-JAN-13.aspx</link><pubDate>4/21/2015</pubDate></item><item><title>Developing a 21st Century Neuroscience Workforce: Workshop Summary</title><description>Given the changing landscape resulting from technological advances and the growing importance of interdisciplinary and collaborative science, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders convened a workshop on October 28 and 29, 2014, in Washington, DC, to explore future workforce needs and how these needs should inform training programs.</description><link>http://www.iom.edu/Reports/2015/21st-Century-Neuroscience-Workforce.aspx</link><pubDate>4/21/2015</pubDate></item><item><title>Workshop 3: Understanding and Preventing Adolescent Risk Behavior Integrating Findings Across Domains of Influence</title><description /><link>http://www.iom.edu/Activities/Children/AdolescenceWS/2009-DEC-14.aspx</link><pubDate>4/20/2015</pubDate></item><item><title>Workshop on Opportunities to Promote Children’s Behavioral Health: Health Care Reform and Beyond</title><description>This workshop will explore how healthcare reform, broadly considered, can provide opportunities and support innovations to promote children’s behavioral health and sustain them over time.  Funding streams, intermediary organizations, and innovative programs and services will be considered.</description><link>http://www.iom.edu/Activities/Children/ChildrensHealthForum/2015-APR-01.aspx</link><pubDate>4/20/2015</pubDate></item><item><title>Evaluation of the Supplemental Security Income (SSI) Disability Programs for Children with Mental Disorders</title><description>The IOM will conduct an evaluation of the Social Security Administration’s (SSA) SSI program for children (birth to the attainment age of 18) with disabilities based on mental disorders to determine the effectiveness of the disability determination process for these children in the context of current trends in child health and development, and in pediatric and adolescent medicine.</description><link>http://www.iom.edu/Activities/MentalHealth/SSIDisabilityPrograms.aspx</link><pubDate>4/13/2015</pubDate></item><item><title>Assessing the Impact of Digital Health Records on Alzheimer's Disease Research (July 20, 2015)</title><description>The Institute of Medicine will host a public session on Assessing the Impact of Digital Health Records on Alzheimer's Disease Research at the 2015 Alzheimer's Association International Conference on Alzheimer's Disease (AAIC). This public workshop will explore how digital health records can be applied to support research on Alzheimer's disease.</description><link>http://www.iom.edu/Activities/Research/NeuroForum/AAIC.aspx</link><pubDate>4/13/2015</pubDate></item><item><title>Providing Sustainable Mental Health Care in Ghana (April 28-29, 2015)</title><description>This workshop will bring together key stakeholders to examine country specific opportunities to improve the health system infrastructure in Ghana.</description><link>http://www.iom.edu/Activities/Research/NeuroForum/Ghana.aspx</link><pubDate>4/13/2015</pubDate></item><item><title>2013-Annual-Report</title><description>2013 Annual Report</description><link>http://www.iom.edu/Activities/Research/NeuroForum/2013-Annual-Report.aspx</link><pubDate>4/13/2015</pubDate></item><item><title>Defining the Expertise Needed for the 21st Century Neuroscience Workforce: A Workshop (October 28-29, 2014)</title><description>Defining the Expertise Needed for the 21st Century Neuroscience Workforce: A Workshop</description><link>http://www.iom.edu/Activities/Research/NeuroForum/Training-2014-Workshop.aspx</link><pubDate>4/13/2015</pubDate></item><item><title>Press Release: Increased Use of Psychological Testing Would Strengthen Process for Social Security Disability Determination</title><description>WASHINGTON – Broader use of standardized psychological testing for applicants submitting disability claims to the U.S. Social Security Administration (SSA) should improve the accuracy and consistency of disability determinations, says a new report from the Institute of Medicine.  </description><link>http://www.iom.edu/Reports/2015/PsychTesting/Press-Release.aspx</link><pubDate>4/10/2015</pubDate></item><item><title>Psychological Testing in the Service of Disability Determination</title><description>The U.S. Social Security Administration (SSA) asked the Institute of Medicine (IOM) to convene a committee of relevant experts to review selected psychological tests, including SVTs and PVTs, and to evaluate the value of and provide guidance on the use of such testing in the adjudication of claims submitted to the SSA Disability Programs. </description><link>http://www.iom.edu/Reports/2015/PsychTesting.aspx</link><pubDate>4/10/2015</pubDate></item><item><title>The Rhoda and Bernard Sarnat International Prize in Mental Health</title><description>The Rhoda and Bernard Sarnat International Prize in Mental Health is awarded annually to individuals, groups, or organizations in order to recognize outstanding achievement in improving mental health services, research, or public policy.</description><link>http://www.iom.edu/Activities/MentalHealth/SarnatPrize.aspx</link><pubDate>4/3/2015</pubDate></item><item><title>Health Implications of Raising the Minimum Age for Purchasing Tobacco Products</title><description>The IOM will establish a committee of public health, medical and other experts to conduct a study and prepare a report to be issued to the Food and Drug Administration (FDA)/ Center for Tobacco Products (CTP) on the likely public health impact of raising the minimum age for purchasing tobacco products.</description><link>http://www.iom.edu/Activities/PublicHealth/TobaccoMinimumAge.aspx</link><pubDate>4/1/2015</pubDate></item></channel></rss>